PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026International Journal of Stroke0 citations

Long-Term Outcomes and Complications of Cerebral Venous Sinus Thrombosis: Findings from the Vellore CVT Registry

View Full Paper
SASanjith AaronAMAngel MiraclinMSMubasheera Sulthana

Key Points

  • To investigate long-term outcomes and complications in patients with cerebral venous sinus thrombosis (CVT).
  • Ambispective study design using the Vellore CVT Registry data.
  • Analyzed 2,484 adults with CVT from 2000 to 2024.
  • Follow-up assessed functional status and complications over a range of up to 12 years.
  • 95.8% survival rate during the acute phase after CVT.
  • 92% achieved excellent functional outcomes (mRS ≤ 2) within 2 years.
  • 33.5% experienced complications during follow-up, with 50.6% requiring rehospitalization.

Abstract

Background: Although short-term outcomes are generally favourable in Cerebral venous sinus thrombosis (CVT), there are limited data on long-term complications and sequelae. Methods: This ambispective study is from the Vellore CVT Registry, the largest single-centre CVT registry in the world. Two thousand four hundred and eighty-four adults with CVT enrolled between 2000 and 2024 were analysed for functional status and complications with follow-up up to 12 years. Results: Out of 2,484 patients, 2,380 (95.8%) survived the acute phase with a mean follow-up of 3.2 years (range, 0–12 years). During follow-up, 41 patients (1.7%) died, the majority being within 1 year. Excellent functional outcomes (mRS ≤ 2) were achieved by 92% of patients within 2 years. Complications were observed in 799 (33.5%) at follow-up, with 405 (50.6%) requiring rehospitalization. More than half (55.1%) of these complications occurred more than 2 years after the initial diagnosis of CVT. Common complications were seizures (9.6%) and headaches (7.7%). Bleeding events occurred in 3.9% of cases, predominantly due to anticoagulant use. Recurrent CVT developed in 1.3%, and other thrombotic events in 2.4%. Occurrences of malignancies (1%) and secondary dural arteriovenous fistulas (dAVFs) (0.6%) were significant complications that occurred after 2 years. Of the 108 pregnancies that occurred during follow-up, thrombotic events occurred in 2.7% in the absence of antithrombotic prophylaxis. Conclusions: Most patients with CVT achieve long-term functional independence, yet one-third develop delayed complications. These findings underscore the importance of long-term surveillance in CVT survivors and give important insights into the natural history of CVT.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Aaron et al. (2026) studied this question.

synapsesocial.com/papers/6996a85cecb39a600b3eefbahttps://doi.org/10.1177/17474930261428115
Ask AI
Helpful
Bookmark
Share
View Full Paper